1. Stent for Life - 2011 . Mohamed Sobhy1, MD; Mohamed Sadaka1, MD; Nireen Okasha2, MD; El Sayed Farag3, MD; Ayman Saleh2, MD; Hussein Ismail4, MD; Mohamed El Seteiha5, MD; Hany Ragy6, MD; Mohamed Abdel Hameed1, MD; Radwa Mehanna1, MD 1. , , , (Faculty of Medicine, Alexandria University, Alexandria, Egypt); 2. , , , (Faculty of Medicine, Ain Shams University, Cairo, Egypt); 3. , , , (Faculty of Medicine, Zagazig University, Zagazig, Egypt); 4. , , , (Faculty of Medicine, Suez Canal University, Port Said, Egypt); 5. , , , (Faculty of Medicine, Tanta University, Tanta, Egypt); 6. , , (National Heart Institute, Cairo, Egypt) * : , , , (Professor of Cardiology, Head of Cardiology Department, Alexandria University, Alexandria, 21527-Egypt). E-mail: sobhy53@yahoo.com : (Primary PCI), ST (STEMI), (myocardial infarction) : , 25-35% . Stent for Life ST . : 14 , 1324 , ST 01 2011 . 14 38 ; ( -); 2011 . - (60,5%), (46,0%), (51,4%) (56,0%). 56,0110,61, 75,0% . 5% ST . 42,7% 25,9% . () 80,7% , () 19,3% . 2,9% (1,4% , 1,1% 0,4% ).: , ST, , , , . . ,

2. , , (1). 25-35% (2). , , . , ; , = (3). . , , (4). 20-40% (5). - . 12 ST, . - , 12 . ST, , , . ST - 3-24 (6). ST, , 120 . , , -, , (7). ACESS (8) , () , , 60% . Stentfor Life (SFL) 10 (9). , , , . , , , , , , ST, , , , , ST , , , , , , ( 1). 3. 1. . SFL , . . SFL SFL 08 2011 . Palestine Hotel (Egyptian Society of Cardiology) (European committee of Practice guidelines) (European Society of Cardiology), (the Egyptian application of the European Practice Guidelines) ( 2). - - CARDIO EGYPT (Sharm El Sheikh). - , Stent for Life. . Stent for Life (Stent for Lifes first Egyptian patient awareness campaign) 23 2011 . - (Alexandria Sporting Club) 200 , . , : ; ; 4. ; . Mohammed Sobhy, , . , . : 22 2012 . (National Heart Institute Egypt). Stent For Life (Stent For Life Board) . 14 01 2011 . ( 3 4). 1324 ST: 688 12 , 504 , 312 , 147 12 , 21 , 33 , 30 93 ( 1). , , ; , -, . , . .Cardio Egypt 2012 39- Cardio Egypt, (Egyptian Society of Cardiology) (Minister of Health and Population) ; Dr.Sobhy . , . (Egyptian Minister of Health and Population) , /:- , ST (Tripartite Committee) , SFL;- , ;- , ;- , .- ST.- .- . , , , (Ministry of Health). .Dr. Ahmed El Shal, , 84 , , . Stent for Life 5. , , . Petr Widimsky , . 2012 ., 2013 . , , ( , , , , ), , , ST, , 23 % -. SPSS version 18.0 (SPSS,Chicago, IL, USA). , , , . 2. Stent for Life. 6. 3. . 7. 4. . 1. (n=1324) %- 68852,0 21 1,6 18 1,4 93 7,0 14711,1 21 1,6 90,7 15 1,1 31223,5 56,0110,61 , 75,0% . - (60,5%), (46,0%), (51,4%), (56,0%) (20,3%) ( 2). 320 . , , 270 . 8. , - 70 . (688). 420 . (147 ). GPIIb/IIIa () - 61,7% 7,5% . 42,7% 25,9% . () 80,7% , () 19,3% ( 3). 2,9% (1,4% , 1,1% 0,4% ). 2. (n=1324) % 21,0-96,0 SD56,0110,6155,0993 75,0331 25,0 681 51,4 742 56,0 609 46,0 801 60,5 269 20,3 3. (n=147) (n=688) %% 117,5424 61,7 3825,9 294 42,7 109 74,1 545 79,23020,4 126 18,3 5 3,4142,0 10 ST . ST (10). , ST , , (11). 9. , 56 , , , , , . , , , . . , , . Saman Rasoul (10) ST (From clinical trial to clinicalpractice). , 1994 2004 . 4732 ST , , (Isala Clinics,Zwolle, Netherlands). 61 (19-95) , 76% , 11% , 11% - , 31,9% - , 48,5% , 44,3% .Y.B. Juwana (12) ST . , 596 , 568 (Zwolle) 28 (Jakarta). (54 63 ), (36% 12%), (46% 19%) (68% 31%).Fahim H. (11) Joint Commission International Accredited Hospital in a Developing at the AgaKhan University Hospital (AKUH) , (Karachi, Pakistan). 277 . 54,911,2 years, 76,5% , 32,1% , 46,9% - , 32,9% , 45,8% , 12,3% .Andrew (13) MERLIN. 307 , , , ; 153 , 63,0 , 71% , 11,8% , 40,5% - , 19,0% - , 41,8% , 11,1% . (688 ) 320 ., - - 70 .Saman Rasoul (10) , 1994 2004 . (3,84,3 ), - 1,00,9 0,90,2 .Y.B. Juwana (12) , (413325 214202 .), (189127 4933.), .Sune Pedersen (14) , - 97 .( 65-135 .), - - 214 .( 145-310 .). 10. Busk M. (15) DANAMI-2, , - 109 ., - - 216. , .Abdessalem S. (16) , 10,96,8 (50% 90 . 144 . 140 ., - 274 .David (19) Rescue Percutaneous Coronary Intervention for FailedThrombolysis ( ). 214 , 178 (83%) . 5,6 , 7,0 . 5. 11. IIb/IIIa - 61,7% 7,5% . 42,7% 25,9% . 80,7% , 19,3% . 5,4% .Sune Pedersen (14) , IIb/IIIa - 28% . 6% . 40% , 37% . Abdessalem S. (16) IIb/IIIa 12% . 96,2% . 48,2% 44,2% 3,8% , .Fahim H. (11) , IIb/IIIa - 90% . 96% , 4%. 4,3% .David (19) , 21% . 88% . IIb/IIIa 92% . 2,9%, , , , , , -, .Abdessalem S. (16) , 5,3%.Fahim H. (11) , 23 (8,3%).Petr Widimsky (17) , ST, , 2,7% 8%. , David (19), 3,4%. . -, , , , . -, . ( , ; , ), . , , , , , , SFL, , . ST; SFL 10 . , , , . 12. . 1. Robert Beaglehole. The World Health Organization Report 2004.2. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998.Circulation. 2001;104:2158-63.3. St. Agnes Healthcare. Early Heart Attack Care. Retrieved November 29, 2006.4. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and prehospitalthrombolysis for acute myocardial infarction: A meta-analysis. JAMA. 2000;28:2686-92.5. Rokos IC, Larson DM, Henry TD, Koenig WJ, Eckstein M, French WJ, Granger CB, Roe MT.Rationale for establishing regional ST-elevation myocardial infarction receiving center (SRC) networks.Am Heart J. 2006;152:661-7.6. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D,Ludbrook P. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison betweenintravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospitaldischarge. Circulation. 1987;76:142-54.7. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, GuytonRA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, NallamothuBK, Ting HH. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report ofthe American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines and the Society for Cardiovascular Angiography and Interventions. Circulation.2011;124:e574-e651.8. ACCESS Investigators. Management of acute coronary syndromes in developing countries:Acutecoronary events-a multinational survey of current management strategies. Am Heart J. 2011; 162:852-859.e229. Kristensen SD, Laut KG, Kaifoszova Z, Widimsky P. Variable penetration of primary angioplasty inEurope - what determines the implementation rate? EuroIntervention. 2012;8:35-42.10. Rasoul S, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Zijlstra F,Suryapranata H, vant Hof AW; Zwolle Myocardial Infarction Study Group. Primary percutaneous coro-nary intervention for STEMI: from clinical trial to clinical practice. Int J Cardiol. 2009;134:104-9.11. Jafary FH, Arham AZ, Waqar F, Raza A, Ahmed H. Survival of patients receiving fibrinolytic therapyfor acute ST-segment elevation myocardial infarction in a developing country - patient characteristics andpredictors of mortality. J Thromb Thrombolysis. 2008; 26:147-9.12. Juwana YB, Wirianta J, Ottervanger JP, Dambrink JH, van t Hof AW, Gosselink AT, Hoorntje J, deBoer MJ, Suryapranata H. Primary coronary intervention for ST-elevation myocardial infarction inIndonesia and the Netherlands: a comparison. Neth Heart J. 2009;17:418-21.13. Sutton AG, Campbell PG, Graham R, Price DJ, Gray JC, Grech ED, Hall JA, Harcombe AA, WrightRA, Smith RH, Murphy JJ, Shyam-Sundar A, Stewart MJ, Davies A, Linker NJ, de Belder MA. Arandomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction(MERLIN) trial. J Am Coll Cardiol. 2004;44:287-96.14. Pedersen S, Galatius S, Mogelvang R, Davidsen U, Galloe A, Abildstrom SZ, Abildgaard U, HansenPR, Bech J, Iversen A, Jorgensen E, Kelbaek H, Saunamaki K, Madsen JK, Jensen JS. Long-termprognosis in an ST-segment elevation myocardial infarction population treated with routine primarypercutaneous coronary intervention: from clinical trial to real-life experience. Circ Cardiovasc Interv.2009;2:392-400.15. Busk M, Maeng M, Rasmussen K, Kelbaek H, Thayssen P, Abildgaard U, Vigholt E, Mortensen LS,Thuesen L, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators. The Danish multicentrerandomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (theDANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J. 2008; 29:1259-66.16. Abdessalem S, Mjadlah S, Mahjoub H, Mourali S, Mechemeche R. Immediate and 12-monthoutcomes of an interventional reperfusion strategy in acute STEMI. Report of 208 successive patients.Tunis Med. 2009;87:755-62.17. Widimsky P, Wijns W, Fajadet J, de Belder M, Knot J, Aaberge L, Andrikopoulos G, Baz JA, BetriuA, Claeys M, Danchin N, Djambazov S, Erne P, Hartikainen J, Huber K, Kala P, Klinceva M, KristensenSD, Ludman P, Ferre JM, Merkely B, Milicic D, Morais J, Noc M, Opolski G, Ostojic M, RadovanovicD, De Servi S, Stenestrand U, Studencan M, Tubaro M, Vasiljevic Z, Weidinger F, Witkowski A, ZeymerU; European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST 13. elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. EurHeart J. 2010; 31:943-57.18. Gershlick AH, Stephens-Lloyd A, Hughes S, Abrams KR, Stevens SE, Uren NG, de Belder A, DavisJ, Pitt M, Banning A, Baumbach A, Shiu MF, Schofield P, Dawkins KD, Henderson RA, Oldroyd KG,Wilcox R; REACT Trial Investigators. Rescue angioplasty after failed thrombolytic therapy for acutemyocardial infarction. N Engl J Med. 2005;353:2758-68.19. Shavelle DM, Salami A, Abdelkarim M, French WJ, Shook TL, Mayeda GS, Burstein S, MatthewsRV. Rescue percutaneous coronary intervention for failed thrombolysis. Catheter Cardiovasc Interv.2006; 67:214-20.